SCOPUS 정보 검색 플랫폼

BMC Infectious Diseases

Volumn 14, Issue , 2014, Pages

No strategy to meet the HCV epidemic

(2) Dalgard, Olav a Mauss, Stefan b

a AKERSHUS UNIVERSITY HOSPITAL (Norway)

b Center for HIV and Hepatogastroenterology (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SIMEPREVIR; SOFOSBUVIR;

AWARENESS; COMORBIDITY; EPIDEMIC; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CANCER; LIVER FAILURE; NONHUMAN; NOTE; PUBLIC HEALTH; TREATMENT OUTCOME; EUROPE;

EPIDEMICS; EUROPE; HEALTH POLICY; HEPATITIS C; HUMANS;

EID: 84929514049 PISSN: None EISSN: 14712334 Source Type: Journal
DOI: 10.1186/1471-2334-14-S6-S2 Document Type: Note

Times cited : (4)

References (7)

1
- 62549157097
- HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality
- Muhlberger N, Schwarzer R, Lettmeier B, Sroczynski G, Zeuzem S, Siebert U: HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health 2009, 9:34.
- (2009) BMC Public Health , vol.9 , pp. 34
- Muhlberger, N.¹ Schwarzer, R.² Lettmeier, B.³ Sroczynski, G.⁴ Zeuzem, S.⁵ Siebert, U.⁶

2
- 85044009866
- Are there national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs? A survey of 33 European countries
- Maticic MVZ, Gregorcic S, Schatz E, Lazarus JV: Are there national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs? A survey of 33 European countries. BMC 2014.
- (2014) BMC
- Maticic, M.V.Z.¹ Gregorcic, S.² Schatz, E.³ Lazarus, J.V.⁴

3
- 84908367148
- Policy responses to viral hepatitis B and C among people who inject drugs in Member States of the WHO European region: a sub-analysis of the WHO 2013 global hepatitis policy survey
- Spina ANT, Eramova I, Lazarus J: Policy responses to viral hepatitis B and C among people who inject drugs in Member States of the WHO European region: a sub-analysis of the WHO 2013 global hepatitis policy survey. BMC 2014.
- (2014) BMC
- Spina, A.N.T.¹ Eramova, I.² Lazarus, J.³

4
- 84892530825
- Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: A longitudinal long-term cohort study
- Kielland KB, Delaveris GJ, Rogde S, Eide TJ, Amundsen EJ, Dalgard O: Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: A longitudinal long-term cohort study. J Hepatol 2014, 60:260-266.
- (2014) J Hepatol , vol.60 , pp. 260-266
- Kielland, K.B.¹ Delaveris, G.J.² Rogde, S.³ Eide, T.J.⁴ Amundsen, E.J.⁵ Dalgard, O.⁶

5
- 84871210488
- All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: a controlled study
- Kielland KB, Skaug K, Amundsen EJ, Dalgard O: All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: a controlled study. J Hepatol 2013, 58:31-37.
- (2013) J Hepatol , vol.58 , pp. 31-37
- Kielland, K.B.¹ Skaug, K.² Amundsen, E.J.³ Dalgard, O.⁴

6
- 79958748633
- A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
- Cornberg M, Razavi HA, Alberti A, Bernasconi E, Buti M, Cooper C, Dalgard O, et al: A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int 2011, 31(Suppl 2):30-60.
- (2011) Liver Int , vol.31 , pp. 30-60
- Cornberg, M.¹ Razavi, H.A.² Alberti, A.³ Bernasconi, E.⁴ Buti, M.⁵ Cooper, C.⁶ Dalgard, O.⁷

7
- 84898990930
- New hepatitis C therapies: the toolbox, strategies, and challenges
- Pawlotsky JM: New hepatitis C therapies: the toolbox, strategies, and challenges. Gastroenterology 2014, 1176, 146:1192.
- (2014) Gastroenterology , vol.1176 , Issue.146 , pp. 1192
- Pawlotsky, J.M.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.